Hypertrophic Cardiomyopathy With Longevity to 90 Years or Older

      Hypertrophic cardiomyopathy (HC) is the most common cause of sudden death in the young, but survival to particularly advanced age is less well appreciated. The investigators report the prevalence, clinical features, and demographics of patients with HC surviving to ≥90 years of age. Of 1,297 patients with HC in the Hypertrophic Cardiomyopathy Center database (Minneapolis Heart Institute Foundation), 26 (2.0%) were identified who had achieved the age of ≥90 years; 18 (69%) were women. HC diagnosis came late in life, at 61 to 92 years (mean 80 ± 8; ≥75 years in 21 patients), recognized fortuitously by the detection of a heart murmur or during family screening (n = 6) or after onset of new symptoms (n = 20). At most recent evaluation (or death) patients were aged 90 to 96.7 years (mean 92.2 ± 2), with 6 presently alive at 91 to 96 years of age; HC did not appear to be the primary cause of death in any patient. Left ventricular wall thicknesses were 15 to 31 mm (mean 20 ± 3); 8 patients (31%) had obstruction to left ventricular outflow at rest (peak instantaneous gradients, 38 to 135 mm Hg). Significant HC-related complications occurred in 13 patients (50%), including progressive heart failure symptoms, atrial fibrillation, and nonfatal embolic stroke. Although no patient died suddenly, 13 (50%) nevertheless carried conventional HC risk markers. A greater proportion of cohort patients reached ≥90 years of age (2.0%) than expected in the general population (0.8%) (p <0.001). In conclusion, HC may be unrecognized until late in life and is consistent with survival to particularly advanced age into the 10th decade of life without the need for major HC-related treatment interventions, and with demise ultimately largely unrelated to this disease. This principle regarding the natural history of HC can afford a measure of reassurance to many patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Maron B.J.
        • McKenna W.J.
        • Danielson G.K.
        • Kappenberger L.J.
        • Kuhn H.J.
        • Seidman C.E.
        • Shah P.M.
        • Spencer III, W.H.
        • Spirito P.
        • Ten Cate F.J.
        • Wigle E.D.
        • American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy
        A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy.
        J Am Coll Cardiol. 2003; 42: 1687-1713
        • Elliott P.M.
        • Poloniecki J.
        • Dickie S.
        • Sharma S.
        • Monserrat L.
        • Varnava A.
        • Mahon N.G.
        • McKenna W.J.
        Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.
        J Am Coll Cardiol. 2000; 36: 2212-2218
        • Elliott P.M.
        • Gimeno Jr, B.
        • Mahon N.G.
        • Poloniecki J.D.
        • McKenna W.J.
        Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.
        Lancet. 2001; 357: 420-424
        • Maron B.J.
        Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.
        Circulation. 2010; 121: 445-456
        • Lewis J.F.
        • Maron B.J.
        Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life.
        J Am Coll Cardiol. 1989; 13: 36-45
        • Dimitrow P.P.
        • Czarnecka D.
        • Kawecka-Jaczca K.
        • Dubiel J.S.
        The influence of age on gender-specific differences in the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy.
        Int J Cardiol. 2003; 88: 11-16
        • Spirito P.
        • Bellone P.
        • Harris K.M.
        • Bernabo P.
        • Bruzzi P.
        • Maron B.J.
        Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy.
        N Engl J Med. 2000; 342: 1778-1785
        • Therneau T.M.
        • Grambsch P.M.
        Modeling Survival Data.
        Springer, New York, New York2000
        • Therneau T.M.
        • Offord J.
        Expected Survival Based on Hazard Rates (Update) 1999 (Mayo Clinic Biostatistics Technical Report 63).
        Mayo Clinic, Rochester, Minnesota1999
        • Arias E.
        • Curtin L.R.
        • Wei R.
        • Anderson R.N.
        U.S. decennial life tables for 1999–2001, United States life tables.
        Natl Vital Stat Rep. 2008; 57: 1-36
        • Klues H.G.
        • Roberts W.C.
        • Maron B.J.
        Morphologic determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy.
        Circulation. 1993; 87: 1570-1579
        • Bos J.M.
        • Maron B.J.
        • Ackerman M.J.
        • Haas T.S.
        • Sorajja P.
        • Nishimura R.A.
        • Gersh B.J.
        • Ommen S.R.
        Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy.
        Am J Cardiol. 2010; 106: 1481-1486
        • Spirito P.
        • Autore C.
        • Rapezzi C.
        • Bernabò P.
        • Badagliacca R.
        • Maron M.S.
        • Bongioanni S.
        • Coccolo F.
        • Estes N.A.
        • Barillà C.S.
        • Biagini E.
        • Quarta G.
        • Conte M.R.
        • Bruzzi P.
        • Maron B.J.
        Syncope and risk of sudden death in hypertrophic cardiomyopathy.
        Circulation. 2009; 119: 1703-1710
        • Maron B.J.
        • Spirito P.
        • Shen W.K.
        • Haas T.S.
        • Formisano F.
        • Link M.S.
        • Epstein A.E.
        • Almquist A.K.
        • Daubert J.P.
        • Lawrenz T.
        • Boriani G.
        • Estes III, N.A.
        • Favale S.
        • Piccininno M.
        • Winters S.L.
        • Santini M.
        • Betocchi S.
        • Arribas F.
        • Sherrid M.V.
        • Buja G.
        • Semsarian C.
        • Bruzzi P.
        Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
        JAMA. 2007; 298: 405-412
        • Teare D.
        Asymmetrical hypertrophy of the heart in young adults.
        Br Heart J. 1958; 20: 1-8
        • Lewis J.F.
        • Maron B.J.
        Clinical and morphologic expression of hypertrophic cardiomyopathy in patients > 65 years of age.
        Am J Cardiol. 1994; 73: 1105-1111
        • Olivotto I.
        • Maron M.S.
        • Adabag A.S.
        • Casey S.A.
        • Vargiu D.
        • Link M.S.
        • Udelson J.E.
        • Cecchi F.
        • Maron B.J.
        Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 2005; 46: 480-487
        • Maron M.S.
        • Olivotto I.
        • Betocchi S.
        • Casey S.A.
        • Lesser J.R.
        • Losi M.A.
        • Cecchi F.
        • Maron B.J.
        Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
        N Engl J Med. 2003; 348: 295-303
        • Seward J.B.
        • Casaclang-Verzosa G.
        Infiltrative cardiovascular diseases; cardiomyopathies that look alike.
        J Am Coll Cardiol. 2010; 55: 1769-1779
        • Ho C.
        Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy.
        Circulation. 2010; 122: 2430-2440
        • Landstrom A.P.
        • Ackerman M.J.
        Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.
        Circulation. 2010; 122: 2441-2449